Stuart Chaussee & Associates, Inc. Clovis Oncology, Inc. Transaction History

Stuart Chaussee & Associates, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 06, 2021	SELL	$5.02 - $7.05 $13,428 - $18,858	-2,675 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$4.81 - $10.34 $12,866 - $27,659	2,675 New	2,675 $19,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Stuart Chaussee & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Stuart Chaussee & Associates, Inc. with notifications on news.